These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22087109)

  • 1. Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors.
    Omidkhoda A; Gharehbaghian A; Jamali M; Ahmadbeigi N; Hashemi SM; Rahimi A; Soleimani M
    Hepat Mon; 2011 Jan; 11(1):11-3. PubMed ID: 22087109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran.
    Rad F; Sajjadi SM; Azizi A; Maghsudlu M
    Transfus Clin Biol; 2019 Nov; 26(4):253-256. PubMed ID: 31174915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience.
    Ameli MR; Hosseini SH; Rad F; Sajjadi SM
    Asian J Transfus Sci; 2021; 15(1):57-61. PubMed ID: 34349458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011.
    Mohammadali F; Pourfathollah AA
    Arch Iran Med; 2014 Sep; 17(9):613-20. PubMed ID: 25204477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the confidential unit exclusion option in blood donors in tehran, iran, determined by using the nucleic Acid testing method in 2008 and 2009.
    Farhadi E; Gharehbaghian A; Karimi G; Samiee S; Tavasolli F; Salimi Y
    Hepat Mon; 2011 Nov; 11(11):907-12. PubMed ID: 22308155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV-NAT implementation at a major public blood bank in the Brazilian Amazon.
    Souza JC; Crispim MAE; Abrahim C; Fraiji NA; Kiesslich D; Stefani MMA
    Transfusion; 2019 Feb; 59(2):629-638. PubMed ID: 30499594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on confidential unit exclusion at Shiraz Blood Transfusion Center, Iran.
    Kasraian L; Karimi MH
    Asian J Transfus Sci; 2016; 10(2):132-5. PubMed ID: 27605850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013.
    Keshvari M; Sharafi H; Alavian SM; Mehrabadi H; Zolfaghari S
    Transfus Apher Sci; 2015 Aug; 53(1):38-47. PubMed ID: 25892591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran.
    Mohammadali F; Pourfathollah A
    Iran J Public Health; 2014 Jul; 43(7):981-9. PubMed ID: 25909065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.
    Saber HR; Tabatabaee SM; Abasian A; Jamali M; SalekMoghadam E; Hajibeigi B; Alavian SM; Mirrezaie SM
    Indian J Hematol Blood Transfus; 2017 Sep; 33(3):412-416. PubMed ID: 28824247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.
    Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA
    J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current impact of the confidential unit exclusion option.
    Zou S; Notari EP; Musavi F; Dodd RY;
    Transfusion; 2004 May; 44(5):651-7. PubMed ID: 15104644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.
    Kim MJ; Park Q; Min HK; Kim HO
    BMC Infect Dis; 2012 Jul; 12():160. PubMed ID: 22817275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Williams AE; Busch MP; Zuck TF; Ownby HE; Matijas LJ; Wright DJ
    Transfusion; 1994 Oct; 34(10):870-6. PubMed ID: 7940658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographics and serological profile of blood donors who opt for the confidential unit exclusion in a blood bank in Sao Paulo, Brazil.
    Delatorre MVV; Batalha KM; Santos LD; Bonet-Bub C; Avelino-Silva VI
    Rev Inst Med Trop Sao Paulo; 2021; 63():e69. PubMed ID: 34495266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study.
    Abdella S; Moshago Berheto T; Tolera G; Belete W; Deressa T; Feleke A; H/Silassie A; Gezahegn N; Tadesse D; Tefera M; Dillnessa E; Kinfu A; Abate E; Kifle T
    PLoS One; 2020; 15(10):e0241086. PubMed ID: 33119668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.